Authors

Digital Therapeutic Shows Promise in Depression Care

APhA 2025: Nakia Eldridge, PharmD, MBA, Highlights Must-See Sessions

Nakia Eldridge, PharmD, MBA, shares insights for health system and community pharmacists attending the 2025 APhA Annual Meeting & Exposition.

RSV Vaccination as a Public Health Priority: Protecting Communities Through Pharmacy Access

Updates in the Management of Transplant-Ineligible Patients With Multiple Myeloma

Explore the latest advancements in treating transplant-ineligible multiple myeloma, highlighting new therapies and clinical trial outcomes for improved patient care.

Designing for Safety: The Pharma Industry’s Role in Preventing Medication Errors

Pharmaceutical companies must consider formulation, packaging, and labeling from the start to minimize errors and protect patients.

Recognizing and Managing Skin Toxicities as Cancer Therapies Evolve

Expert highlights the critical need to manage skin toxicities in oncology, ensuring effective cancer treatments while addressing patient well-being and adherence.

Regimens, Adherence, and Adverse Events: The Role of the Pharmacist in Asthma Management

Collaborative health care efforts are needed to effectively manage asthma, and pharmacists play a key role in optimizing asthma treatment plans.

Healing Trust in Medicine in a Fractured Post-Pandemic Landscape

The pandemic’s aftermath left lasting tensions in health care.

Pharmacy Technicians as Non-Pharmacist Preceptors for a Sterile Compounding Rotation

Recognizing pharmacy technicians as non-pharmacist preceptors can provide an opportunity for professional development while encouraging technicians to practice at the top of their education and training activities.

Drafts, Laughs, and Lasting Lessons: Inside a Unique Medical Writing Experience

The University of Connecticut's Medical Writing Certificate program transforms aspiring writers into confident communicators through hands-on training and real-world experience.

Phage Therapy: Exploring the Future of Infection Treatment

Phage therapy, which uses lytic bacteriophages to target antibiotic-resistant bacteria, has resurfaced as a promising treatment for multidrug-resistant infections, but faces challenges in regulation, production, and clinical implementation despite its growing evidence of efficacy.

Redefining Roles: Technicians Reduce Oncology Drug Waste in Specialty Pharmacy

A technician-driven workflow implemented in a health system’s specialty pharmacy reduced high-cost oncology drug waste.

Medication Management and Supply Chain Still Underwater: Challenges and Future Trends in Health Care

Circulating Tumor DNA (ctDNA) Testing to Predict Response in Solid Tumors

ctDNA analysis revolutionizes cancer treatment by predicting responses, detecting resistance, and monitoring minimal residual disease in patients.

FINEARTS-HF Analysis: How Liver Biomarkers Influence Heart Failure Risk

Jawad Butt, MD, offers insight into his analysis of the FINEARTS-HF trial.

Connecticut Pharmacists Association Marks 150 Years of Advocacy, Innovation, and Service

This milestone celebration not only honors CPA’s legacy but also underscores the profession’s future—one defined by collaboration, innovation, and a steadfast commitment to patient care.

Half of Pharmacy Technicians Feel Fulfilled in Their Current Role

The Connecticut Society of Health-System Pharmacists Technician Committee survey explores the perception of career growth opportunities and challenges.

Connecticut Pharmacists Association Marks 150 Years of Advocacy, Innovation, and Service

This milestone celebration not only honors CPA’s legacy but also underscores the profession’s future—one defined by collaboration, innovation, and a steadfast commitment to patient care.

Enlicitide Meaningfully Lowers LDL-C at 24 Weeks in Patients At Risk for ASCVD Events

Full results detailing the safety and efficacy of enlicitide decanoate, an oral PCSK9 inhibitor, were published in The New England Journal of Medicine.

The Pharmacy Model Is Changing

Embracing artificial intelligence and other tools will be necessary to push the field forward.

The Evolving Fellowship Application Process

The process provides an opportunity for personal and professional growth.

Newly Approved Specialty Drugs Advance Care for Inflammatory and Autoimmune Diseases

Optimizing Infusion Chair Time for Oncology Trials: Follow-Up Study

This study evaluated factors affecting the duration of the infusion appointment times for 392 clinical trial patients.

Afamitresgene autoleucel: The First T-Cell Receptor Therapy on the Market

Second-line and later treatment options for synovial sarcoma are limited. Afamitresgene autoleucel is the first FDA-approved T-cell receptor therapy, demonstrating long-lasting responses and tolerable adverse effects in pretreated patients.

Updated European MASLD Guidelines Review Prevention, Screening, and Treatments

Patients should be supported by a multidisciplinary team, frequent evaluations, and behavioral therapy for optimal care.

PBM Reform Within 2026 Appropriations Bill Signed Into Law

Legislation targeting the practices of pharmacy benefit managers (PBMs) was passed by Congress and signed by the president, with the goal of greater transparency and increased pharmacy access.

Closing Thoughts from the Experts

This final segment consists of expert clinicians offering key takeaways to help pharmacists prepare for potential approvals and integrate new TNBC therapies into practice.

DPYD Testing Gains Ground: NCCN Guideline Update Reflects Decades of Work Toward Safer Chemotherapy

Navigating Pediatric Atopic Dermatitis: Insights Into Treatment, Challenges, and Care Considerations

Atopic dermatitis significantly impacts quality of life, and requires personalized management through trigger identification, skin barrier maintenance, and a range of topical, oral, and biologic therapies to reduce symptoms and prevent flare-ups.

HOPA 2025: Insights Into Post-Transplant Cyclophosphamide Use for Graft-Versus-Host Disease Prevention

Lauren Dietz, PharmD, highlighted the role of oncology pharmacists in guiding prophylaxis decisions to optimize transplant outcomes.